This award funds product-driven research focused on developing therapeutics and diagnostics for Lyme disease and other tick-borne diseases. Therapeutic projects should be early/preclinical evaluations aimed at drug or treatment discovery. Diagnostic projects must propose approaches ready for clinical integration, all aiming to improve patient outcomes and quality of life.
Open to any type of entity, with potential clarifications in additional eligibility information. No specific restrictions stated.
